Topic Paragraphs
Featured Topics
FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Oct 18
Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby Powder in the United States
Cosmetics
Oct 15
Peekay International Inc. Issues Alert on Undeclared Sulfites in “KESHAV Dry Apricot”
Food & Beverages
Oct 15
Viatrexx Bio Incorporated Issues Voluntary Nationwide Recall of Sterile Injectables Due to a Lack of Sterility Assurance
Drugs
FDA Voices: Perspectives from FDA Experts
Expanding Criminal Enforcement Operations Globally to Protect Public Health
FDA’s inspections, investigations, and law enforcement operations are led by FDA's Office of Regulatory Affairs.
The FDA’s Critical Focus on Women’s Health
The FDA takes very seriously its long-standing commitment and approach to women’s health.
FDA’s Comprehensive Response to HIV — Part II
FDA plays a pivotal role in advancing HIV therapies in underserved global markets through the President’s Emergency Plan for AIDS Relief (PEPFAR).
Recently Published Guidances
Oct 18
Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis
Drugs
Oct 18
Drug Master Files Guidance for Industry
Drugs
Oct 16
Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry
Biologics, Drugs